Picture ConsulTech GmbH Forschungszulage 650x80px
Document › Details

Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert.

Organisations Organisation Celyad S.A. (Euronext Brussels + Paris: CYAD, Nasdaq: CYAD)
  Group Celyad (Group)
  Organisation 2 Mesoblast Ltd. (ASX: MSB, Nasdaq: MESO)
Products Product shRNA technology
  Product 2 CYAD-01 (CAR-T NKG2D) CAR-T cell therapy
Persons Person Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007)
  Person 2 Zelkovic, Sara (LifeSci 201810 LifeSci Public Relations)

Record changed: 2019-04-06


Picture [iito] No Tracking 650x80px

More documents for Celyad (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture [iito] Made Without Love 650x80px

» top